发布文献求助

赚大钱

Lv1

40 积分 2024-04-16 加入

最近求助
最近应助
互助留言

Downregulation of CollagenCOL4A6Is Associated with Prostate Cancer Progression and Metastasis 1天前 已完结
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial 3个月前 已完结
Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone 7个月前 已完结
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention 7个月前 已关闭
A multicenter, randomized phase II trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors 7个月前 已关闭
肿瘤治疗所致血小板减少症诊疗指南 8个月前 已完结
A multicenter, randomized phase II trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors. 2023 European Congress of Internal Medicine, Abstract 2360 8个月前 已关闭
A multicenter, randomized phase ii trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors 8个月前 已关闭
A retrospective case series assessing the efficacy and tolerability of romiplostim for the treatment of chemotherapy induced thrombocytopenia (CIT) in cancer patients: the UK experience 8个月前 已关闭
9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC) 8个月前 已完结

没有进行任何应助

找到了【积分已退回】 7个月前
un Ma, Yusheng Wang, Jun Yao, et al. A multicenter, randomized phase II trial on the efficacy and safety of hetrombopag for the treatment of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors. 2023 European Congress of Internal Medicine, Abstract 2360. 7个月前
不需要【积分已退回】 8个月前
不需要【积分已退回】 8个月前
发布错误【积分已退回】 8个月前

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2025 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：941272744【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通